(PDF) Treatment Efficacy of All-Oral Combinations of

Treatment Efficacy of All-Oral Combinations of Direct-Acting Antivirals in Chronic Hepatitis C Patients With NS5A-P32 Deletion

Acta Hepatologica Japonica - Japan

doi 10.2957/kanzo.58.671

Full Text

Abstract

Available in full text

Categories

Date

January 1, 2017

Authors

Mariko Kobayashi

Fumitaka Suzuki

Yoshiyuki Suzuki

Shynichirou Fujiyama

Masahiro Kobayashi

Yusuke Kawamura

Hiromitsu Kumada

Publisher

Japan Society of Hepatology

Related search

Hepatitis B Reactivation in Chronic Hepatitis C Patients Treated With Interferon or Pan-Oral Direct-Acting Antivirals

English

High Efficacy of Generic and Brand Direct Acting Antivirals in Treatment of Chronic Hepatitis C.

International Journal of Infectious Diseases

Infectious Diseases

English

Treatment Efficacy for Patients With Chronic Hepatitis C and Preexisting Hepatocellular Carcinoma by Directly Acting Antivirals

Hepatoma Research

English

Direct Acting Antivirals for the Treatment of Chronic Viral Hepatitis

Environmental Science

Biological Sciences

English

Editorial: Direct-Acting Antivirals Decrease the Frequency of Diabetes Complications in Patients With Chronic Hepatitis C

Alimentary Pharmacology and Therapeutics

Gastroenterology

English

Letter: Low Rates of HBV Serology Testing in Patients With Chronic Hepatitis C Receiving Direct Acting Antivirals

Alimentary Pharmacology and Therapeutics

Gastroenterology

English

Direct-Acting Antivirals for the Treatment of Chronic Hepatitis C: Open Issues and Future Perspectives

The Scientific World Journal

Molecular Biology

Environmental Science

English

Retreatment With Direct-Acting Antivirals of Genotypes 1-3-4 Hepatitis C Patients Who Failed an Anti-Ns5a Regimen in Real World

Journal of Hepatology

English

NS5A-P32 Deletion After Failure of Ledipasvir/Sofosbuvir in Hepatitis C Virus Genotype 1b Infection

English